*Department of Nephrology, Columbia University, New York, New York; †University of Miami, Miller School of Medicine, Miami, Florida; ‡Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina; §Department of Medicine, SUNY-Downstate Medical Center, New York, New York; ‖Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom; ¶Renal Unit, Addenbrooke's Hospital, Cambridge, United Kingdom; **Research Institute of Nephrology, Nanjing, China; ††Organizacio[Combining Acute Accent]n Me[Combining Acute Accent]dica de Investigacio[Combining Acute Accent]n, Buenos Aires, Argentina; ‡‡Instituto Nacional de Ciencias Me[Combining Acute Accent]dicas y Nutricio[Combining Acute Accent]n, Salvador Zubira[Combining Acute Accent]n, Me[Combining Acute Accent]xico; §Aspreva Pharmaceuticals Corporation, Victoria, British Columbia, Canada; and ‖Department of Medicine, University of California, San Francisco, California
Correspondence: Dr. Neil Solomons, Aspreva Pharmaceuticals Corporation, #1203, 4464 Markham Street, Victoria, BC V8Z7X8, Canada. Phone: 250-708-4287; Fax: 254-744-2498; E-mail: [email protected]
Accepted December 5, 2008
Received October 1, 2008
